HIV
Clinical trials for HIV explained in plain language.
Never miss a new study
Get alerted when new HIV trials appear
Sign up with your email to follow new studies for HIV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental HIV vaccine trial ends early – what we know
Vaccine Stopped earlyThis early-stage trial tested an experimental HIV vaccine in 44 healthy adults to see if it was safe and triggered an immune response. The vaccine uses a piece of the HIV virus (fusion peptide) to train the body's defenses. The study was terminated early, so the full results are …
Matched conditions: HIV
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
Can texts and peers help trans women beat HIV? trial cut short
Disease control Stopped earlyThis study aimed to find the best way to help transgender women living with HIV reach undetectable viral levels. Participants received either text messages, help from a peer health navigator, or both. The trial was ended early, so results are limited.
Matched conditions: HIV
Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a 3-Month TB cocktail replace the standard 6-Month regimen?
Disease control Stopped earlyThis clinical trial investigates whether a 3-month combination of clofazimine and rifapentine can effectively treat drug-susceptible tuberculosis (TB) compared to the standard 6-month regimen. The study includes adults with pulmonary TB, some of whom also have HIV. Researchers ar…
Matched conditions: HIV
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
HIV drug switch may boost heart health and trim body fat
Disease control Stopped earlyThis study looked at whether switching from a standard HIV drug combination to a different one (Delstrigo) could improve cholesterol, body fat, and blood sugar in people with HIV. The study planned to enroll 60 adults whose HIV was already well-controlled. Participants were rando…
Matched conditions: HIV
Phase 4 • Sponsor: Chelsea and Westminster NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
HIV Antibody-Only therapy falls short in Long-Term trial
Disease control Stopped earlyThis study tested whether a single antibody called PRO 140 could keep HIV under control in 20 adults who had been stable on standard combination therapy. Participants stopped their usual HIV pills and received only PRO 140 infusions. The trial was stopped early, and the main goal…
Matched conditions: HIV
Phase 2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New approach aims to boost HIV prevention in LGBTQ+ individuals struggling with addiction
Prevention Stopped earlyThis study tested a program to help HIV-negative transgender women and men who have sex with men who also have a substance use disorder stick with PrEP, a daily pill or shot that prevents HIV. Participants received counseling and text support, with extra help for those who strugg…
Matched conditions: HIV
Sponsor: Friends Research Institute, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
CBD shows promise for emotional health in HIV patients
Symptom relief Stopped earlyThis study tested whether synthetic cannabidiol (CBD) could help people living with HIV who have a condition called alexithymia, which makes it hard to recognize and describe emotions. Participants took either CBD or a placebo for 4 weeks. The goal was to see if CBD could improve…
Matched conditions: HIV
Phase 2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Pregnancy drug study aims to protect moms and babies from HIV and TB
Knowledge-focused Stopped earlyThis study looked at how HIV and tuberculosis (TB) medications are processed in the bodies of pregnant women and new mothers. Researchers measured drug levels in the blood of 205 women during pregnancy and after delivery to see if standard doses are effective. The goal was to gat…
Matched conditions: HIV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Web tool aims to boost HIV testing among black women in the south
Knowledge-focused Stopped earlyThis study tested a web-based program to help Black women in Texas use HIV and STI home tests and connect to treatment or PrEP. The program included five sessions with goal-setting and action plans. Only 31 women enrolled before the study was stopped early, so the findings are li…
Matched conditions: HIV
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can cheap text messages boost HIV retesting? pilot study seeks answers
Knowledge-focused Stopped earlyThis pilot study tested several low-cost behavioral nudges, like videos and text messages, to encourage HIV retesting among 98 adults at higher risk of HIV in rural Kenya and Uganda. The goal was to see which approaches were acceptable and feasible, so the best ones could be used…
Matched conditions: HIV
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC